Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310172244> ?p ?o ?g. }
- W4310172244 endingPage "5810" @default.
- W4310172244 startingPage "5810" @default.
- W4310172244 abstract "Lung cancer is the leading cause of cancer-related death worldwide. Since prognosis of early-stage non-small cell lung cancer (NSCLC) remains dismal for common relapses after curative surgery, considerable efforts are currently focused on bringing immunotherapy into neoadjuvant and adjuvant settings. Previously, perioperative chemotherapy showed only a modest but significative improvement in overall survival. The presence of broad tumor neoantigens load at primary tumor prior to surgery as well as the known immunosuppressive status following resection represent the main rationale for immunotherapy in early disease. Several trials have been conducted in recent years, leading to atezolizumab and nivolumab approval in the adjuvant and neoadjuvant setting, respectively, and perioperative immunotherapy in NSCLC remains a field of active clinical and preclinical investigation. Unanswered questions in perioperative therapy in NSCLC include the optimal sequence and timing of chemotherapy and immunotherapy, the potential of combination strategies, the role of predictive biomarkers for patient selection and the choice of useful endpoints in clinical investigation." @default.
- W4310172244 created "2022-11-30" @default.
- W4310172244 creator A5003880441 @default.
- W4310172244 creator A5008674075 @default.
- W4310172244 creator A5011928740 @default.
- W4310172244 creator A5014381245 @default.
- W4310172244 creator A5023226735 @default.
- W4310172244 creator A5031726098 @default.
- W4310172244 creator A5034499343 @default.
- W4310172244 creator A5045416042 @default.
- W4310172244 creator A5047146014 @default.
- W4310172244 creator A5056367409 @default.
- W4310172244 creator A5056639598 @default.
- W4310172244 creator A5059165996 @default.
- W4310172244 creator A5060856474 @default.
- W4310172244 creator A5062479121 @default.
- W4310172244 creator A5066342388 @default.
- W4310172244 creator A5073409422 @default.
- W4310172244 creator A5075146686 @default.
- W4310172244 creator A5079522227 @default.
- W4310172244 creator A5082055508 @default.
- W4310172244 creator A5084583015 @default.
- W4310172244 date "2022-11-25" @default.
- W4310172244 modified "2023-10-14" @default.
- W4310172244 title "Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review" @default.
- W4310172244 cites W1600879661 @default.
- W4310172244 cites W1771257283 @default.
- W4310172244 cites W1916715489 @default.
- W4310172244 cites W1966050071 @default.
- W4310172244 cites W1967367409 @default.
- W4310172244 cites W1971740062 @default.
- W4310172244 cites W1996997726 @default.
- W4310172244 cites W1998045778 @default.
- W4310172244 cites W2017576359 @default.
- W4310172244 cites W2036067943 @default.
- W4310172244 cites W2061551675 @default.
- W4310172244 cites W2073503439 @default.
- W4310172244 cites W2098949852 @default.
- W4310172244 cites W2104504726 @default.
- W4310172244 cites W2107575355 @default.
- W4310172244 cites W2127233803 @default.
- W4310172244 cites W2128628626 @default.
- W4310172244 cites W2134291074 @default.
- W4310172244 cites W2141669181 @default.
- W4310172244 cites W2143994426 @default.
- W4310172244 cites W2146910255 @default.
- W4310172244 cites W2163351155 @default.
- W4310172244 cites W2192941146 @default.
- W4310172244 cites W2210453860 @default.
- W4310172244 cites W2291298003 @default.
- W4310172244 cites W2339737469 @default.
- W4310172244 cites W2341604280 @default.
- W4310172244 cites W2404259999 @default.
- W4310172244 cites W2461271870 @default.
- W4310172244 cites W2521503673 @default.
- W4310172244 cites W2583626096 @default.
- W4310172244 cites W2596438262 @default.
- W4310172244 cites W2606750360 @default.
- W4310172244 cites W2747610372 @default.
- W4310172244 cites W2754606968 @default.
- W4310172244 cites W2793623371 @default.
- W4310172244 cites W2794137041 @default.
- W4310172244 cites W2798160602 @default.
- W4310172244 cites W2803008451 @default.
- W4310172244 cites W2886689398 @default.
- W4310172244 cites W2888941300 @default.
- W4310172244 cites W2891506228 @default.
- W4310172244 cites W2894796660 @default.
- W4310172244 cites W2904370794 @default.
- W4310172244 cites W2906932524 @default.
- W4310172244 cites W2914761223 @default.
- W4310172244 cites W2920151666 @default.
- W4310172244 cites W2939955202 @default.
- W4310172244 cites W2994223194 @default.
- W4310172244 cites W3003197494 @default.
- W4310172244 cites W3003310139 @default.
- W4310172244 cites W3005124847 @default.
- W4310172244 cites W3005326482 @default.
- W4310172244 cites W3006038212 @default.
- W4310172244 cites W3015451486 @default.
- W4310172244 cites W3021010739 @default.
- W4310172244 cites W3082106558 @default.
- W4310172244 cites W3086555948 @default.
- W4310172244 cites W3087210493 @default.
- W4310172244 cites W3088357387 @default.
- W4310172244 cites W3088387563 @default.
- W4310172244 cites W3088673044 @default.
- W4310172244 cites W3089266118 @default.
- W4310172244 cites W3095640895 @default.
- W4310172244 cites W3112225025 @default.
- W4310172244 cites W3128646645 @default.
- W4310172244 cites W3132841322 @default.
- W4310172244 cites W3137318920 @default.
- W4310172244 cites W3138819319 @default.
- W4310172244 cites W3140565772 @default.
- W4310172244 cites W3149803934 @default.
- W4310172244 cites W3170024542 @default.
- W4310172244 cites W3180564569 @default.